The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Dextromethorphan hydrobromide, Guaifenesin, Phenylephrine hydrochloride · DEXTROMETHORPHAN HYDROBROMIDE 7.5 mg/2.5mL; PHENYLEPHRINE HYDROCHLORIDE 5 mg/2.5mL; GUAIFENESIN 150 mg/2.5mL · Solution · Oral · Dextrum Laboratories Inc.
NDC 65852-0011-04 · 1 BOTTLE, PLASTIC in 1 CARTON / 118 mL in 1 BOTTLE, PLASTIC · OTC MONOGRAPH DRUG · View full market →
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Actipharma, Llc | DEXTROMETHORPHAN HYDROBROMIDE 30 mg/5mL; GUAIFENESIN 200 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| DeMoulas Market Basket | DEXTROMETHORPHAN HYDROBROMIDE 20 mg/20mL; GUAIFENESIN 400 mg/20mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Dextrum Laboratories Inc. | DEXTROMETHORPHAN HYDROBROMIDE 7.5 mg/2.5mL; PHENYLEPHRINE HYDROCHLORIDE 5 mg/2.5mL; GUAIFENESIN 150 mg/2.5mL | Aug 26, 2026 | Sep 2, 2026 |
| Dextrum Laboratories Inc. | DEXTROMETHORPHAN HYDROBROMIDE 15 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/5mL; GUAIFENESIN 300 mg/5mL | Aug 26, 2026 | Sep 2, 2026 |
| Gil Pharmaceutical Corp | DEXTROMETHORPHAN HYDROBROMIDE 15 mg/5mL; GUAIFENESIN 300 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Gil Pharmaceutical Corp | DEXTROMETHORPHAN HYDROBROMIDE 7.5 mg/2.5mL; GUAIFENESIN 150 mg/2.5mL; PHENYLEPHRINE HYDROCHLORIDE 5 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| Dextrum Laboratories Inc. | DEXTROMETHORPHAN HYDROBROMIDE 15 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 300 mg/5mL; GUAIFENESIN 10 mg/5mL | Jul 22, 2026 | Aug 19, 2026 |
| Dextrum Laboratories Inc. | DEXTROMETHORPHAN HYDROBROMIDE 7.5 mg/2.5mL; PHENYLEPHRINE HYDROCHLORIDE 150 mg/2.5mL; GUAIFENESIN 5 mg/2.5mL | Jul 22, 2026 | Aug 19, 2026 |
| Dextrum Laboratories Inc. | DEXTROMETHORPHAN HYDROBROMIDE 7.5 mg/2.5mL; GUAIFENESIN 150 mg/2.5mL; PHENYLEPHRINE HYDROCHLORIDE 5 mg/2.5mL | Jul 15, 2026 | Jul 15, 2026 |
| Dextrum Laboratories Inc. | DEXTROMETHORPHAN HYDROBROMIDE 15 mg/5mL; GUAIFENESIN 300 mg/5mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/5mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Giltuss Childrens Cough and Cold — NDC 65852-0011-04," retrieved September 3, 2026, https://drugdashboards.com/drug/65852001104.
Free to cite with attribution — see how the data is put together.